The compound is called cannabizetol (CBGD), and it’s only the fourth dimeric cannabinoid ever identified in cannabis. When researchers tested it against 84 different inflammatory genes, it showed significantly higher anti-inflammatory activity than any previously studied dimeric cannabinoid. It works through the NF-κB pathway—essentially a master switch for inflammation throughout the human body—and exhibits powerful antioxidant properties that could have applications in dermatology, chronic inflammation, and potentially dozens of other medical conditions we haven’t even imagined yet.
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…
Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…
On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…
Is cannabis a miracle cure or a gateway to ruin? We break down the latest…